NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Delhi's private hospitals violating COVID-19 guidelines, say inspection teams
    India

    Delhi's private hospitals violating COVID-19 guidelines, say inspection teams

    Delhi's private hospitals violating COVID-19 guidelines, say inspection teams
    Written by Siddhant Pandey
    Dec 06, 2020, 02:21 pm 3 min read
    Delhi's private hospitals violating COVID-19 guidelines, say inspection teams

    An inspection conducted by government-constituted teams has flagged several violations of COVID-19 management guidelines by private hospitals and nursing homes in Delhi. After surveying 114 private facilities in the national capital on November 17 and 18, the teams suggested tighter restrictions at these facilities, Hindustan Times reported. The report pointed out that facilities were needlessly testing patients with mild/moderate infections and using therapies improperly.

    Mild, moderate cases tested before discharge

    The report noted that as per guidelines, only severe cases of COVID-19 are required to be tested using RT-PCR prior to discharge, while moderate or mild cases can be discharged after three consecutive days of no fever without testing. However, it was noted in the report that all private hospitals inspected were testing every COVID-19 patient before discharge.

    Use of drugs, treatments not as per guidelines

    A majority of hospitals were using drugs and treatments based on the clinical judgment of respiratory physicians, general physicians working in these hospitals, the report said. It said hospitals were found using favipiravir, doxycycline, azithromycin, ivermectin to treat COVID-19 when they are not prescribed in the government protocol. It also noted that investigational therapies such as remdesivir and convalescent plasma therapy were used "routinely."

    Inspectors satisfied with facilities' reservation of ICU beds

    However, the inspectors said that they were satisfied with the facilities' compliance with the government's direction to reserve a certain percentage of ICU beds for COVID-19 patients. Last month, 42 private hospitals were asked to reserve 80% of ICU beds for COVID-19 patients.

    Report included in affidavit by Centre to Supreme Court

    The findings were presented to the Director-General of Health Services and the report is now included in an affidavit by the Centre to the Supreme Court. The top court is hearing a matter over the steps taken by the central and state governments to tackle the COVID-19 outbreak. The DGHS has recommended a special vigil on private facilities to ensure compliance with guidelines.

    Report suggests restrictive order to avoid misuse of drugs

    The report suggested a special restrictive order to avoid misuse of drugs not recommended by the Health Ministry. It also urged the Delhi government to consider appointing nodal officers for monitoring the performance of all these hospitals regularly.

    Doctors should have 'some leeway' in treating patients, experts argue

    However, treatments for COVID-19 are still evolving and most therapies are experimental, experts argued. Nathealth Senior Vice President Dr. Harsh Mahajan said several studies say opposite things about many therapies and doctors are relying on their clinical experience. "Even the national protocol is dynamic." Delhi Medical Council President Dr. Arun Gupta said there should be "some leeway" to decide what works for patients.

    'Plasma therapy of not much use'

    Dr. Samiran Panda—the head of epidemiology and communicable diseases at ICMR and a member of the National Task Force on COVID-19 management—said, "(Plasma therapy) isn't of much use based on the evidence that we have, and our revised guidelines were drastically modified for reference of those wanting to administer it." "It hasn't been banned but there are clear-cut dos and don'ts..."

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Supreme Court Of India
    Hindustan Times
    Ministry of Health and Family Welfare
    Coronavirus

    Latest

    Jos Buttler registers his 11th ODI century; surpasses 4,500 runs Jos Buttler
    3rd T20I: Ton-up Gill powers India to 234/4 versus NZ India vs New Zealand Cricket
    Dawid Malan hits his 3rd ODI century: Key stats Dawid Malan
    Gill becomes seventh Indian to slam a century in T20Is India vs New Zealand Cricket

    Supreme Court Of India

    Modi documentary: SC to hear petitions challenging ban next week 2002 Gujarat Riots
    'Diatribe': Ex-Supreme Court justice Nariman slams Rijiju over collegium remarks  Kiren Rijiju
    Kiren Rijiju questions SC Collegium's conduct for publicizing 'secret reports' Kiren Rijiju
    Google makes sweeping changes to the Android ecosystem in India  Google

    Hindustan Times

    India's COVID-19 vaccination campaign crosses milestone of 2 billion doses Narendra Modi
    No foreign leader as R-Day chief guest this year: Report Narendra Modi
    Ahead of nationwide exercise, COVID-19 vaccine dry run in Haryana India
    Fashion designer Swapnil Shinde comes out as a transwoman Mumbai

    Ministry of Health and Family Welfare

    Marion Biotech, linked to Uzbekistan kids' death, halts production   Uttar Pradesh
    Uzbekistan links death of 18 kids to Noida-made cough syrup Noida
    COVID-19 test mandatory for arrivals from China, 4 other countries COVID-19
    Mumbai's measles death tally reaches 12, Centre issues advisory Measles

    Coronavirus

    COVID-19 outbreak has infected 80% of Chinese population China
    COVID-19: WHO urges travelers to mask up amid XBB.1.5 spread World Health Organization
    China: Hospitals cancel New Year holidays to meet patients' requirements China
    #NewsBytesExplainer: What's XBB.1.5, COVID-19 sub-variant triggering cases spike in US  COVID-19

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023